Clinical Trials Directory

Trials / Completed

CompletedNCT01044888

Heparin Resistance: Predictors and Outcomes

Heparin Resistance During Off-pump Coronary Artery Bypass Graft Surgery: Predictors and Clinical Implication

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
199 (actual)
Sponsor
Yonsei University · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

The investigators evaluated clinical impact of reduced heparin responsiveness (HRreduced) on the incidence of perioperative myocardial infarction (MI) and restenosis at 6 months after off-pump coronary artery bypass graft surgery (OPCAB) and identified its predictors.

Conditions

Interventions

TypeNameDescription
DRUGHeparin150 U/kg heparin was administered intravenously at the beginning of graft anastomosis and accepted a perioperative ACT value of around 300 s. Ten minutes after the loading dose, the ACT was measured. An ACT of 300 s or greater was considered as adequate. Then follow up ACT measurement was determined after 30 min from the previous ACT measurement. If ACT fell below the target value of 300 s, an additional dose of heparin was administered. If ACT was between 250 and 299 s, additional 2000 U of heparin was administered and if ACT was between 200 and 249 s then additional 3000 U of heparin was injected. Ten minutes after additional heparin injection, ACT was remeasured.

Timeline

Start date
2007-04-01
Primary completion
2008-03-01
Completion
2008-09-01
First posted
2010-01-08
Last updated
2012-02-02

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT01044888. Inclusion in this directory is not an endorsement.